Vaccines and febrile seizures

Expert Review of Vaccines

Volumn 12, Issue 8, 2013, Pages 885-892

  Principi, Nicola ^a   Esposito, Susanna ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

febrile seizures; influenza vaccine; measles containing vaccines; pertussis vaccines; prevention; vaccines; varicella vaccine

Indexed keywords

4CMENB; CHICKENPOX MEASLES MUMPS RUBELLA VACCINE; CHICKENPOX VACCINE; DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; DIPHTHERIA PERTUSSIS TETANUS POLIOMYELITIS HEPATITIS B HAEMOPHILUS INFLUENZA TYPE B VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; FLUVAX JUNIOR; INFLUENZA VACCINE; MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE; MENINGOCOCCUS VACCINE; PCV 7; PERTUSSIS VACCINE; PLACEBO; PNEUMOCOCCUS VACCINE; PRIOTIX TETRA; SODIUM CHANNEL; UNCLASSIFIED DRUG;

ADVERSE OUTCOME; ATTITUDE TO VACCINATION; CHICKENPOX; CHILD; CHILD HEALTH CARE; CHILDHOOD DISEASE; DIPHTHERIA; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG FORMULATION; DRUG LABELING; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ETHNIC GROUP; FEBRILE CONVULSION; FEVER; GENE MUTATION; GENETIC PREDISPOSITION; HAEMOPHILUS INFECTION; HEALTH HAZARD; HEPATITIS B; HUMAN; IMMUNE RESPONSE; INFANT; INFLUENZA; INFLUENZA VACCINATION; MEASLES; MEASLES VACCINATION; MEDICAL RECORD REVIEW; MENINGOCOCCOSIS; META ANALYSIS (TOPIC); MUMPS; NEISSERIA MENINGITIDIS; NEUROLOGICAL COMPLICATION; OUTCOMES RESEARCH; PANDEMIC INFLUENZA; PARENTAL ATTITUDE; PERTUSSIS; PHYSICIAN ATTITUDE; PNEUMOCOCCAL INFECTION; POLIOMYELITIS; POSTMARKETING SURVEILLANCE; PRESCHOOL CHILD; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT INFECTION; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RUBELLA; SEIZURE; SEVERE MYOCLONIC EPILEPSY IN INFANCY; TETANUS; VACCINATION;

DISEASE SUSCEPTIBILITY; HUMANS; INCIDENCE; INFLUENZA VACCINES; MEASLES VACCINE; PERTUSSIS VACCINE; PRODUCT SURVEILLANCE, POSTMARKETING; SEIZURES, FEBRILE;

EID: 84887749129     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.2013.814781     Document Type: Review

References (73)

1. Steering Committee on Quality Improvement and Management, Subcommittee on Febrile Seizures American Academy of Pediatrics. Febrile seizures: Clinical practice guideline for the long-term management of the child with simple febrile seizures. Pediatrics 121, 1281-1286 (2008
2. Kjeldsen MJ, Kyvik KO, Friis ML, Christensen K. Genetic and environmental factors in febrile seizures: A Danish population-based twin study. Epilepsy Res. 51(1-2), 167-177 (2002
3. Offringa M, Bossuyt PM, Lubsen J et al. Risk factors for seizure recurrence in children with febrile seizures: A pooled analysis of individual patient data from five studies. J. Pediatr. 124(4), 574-584 (1994
4. Herrgärd EA, Karvonen M, Luoma L et al. Increased number of febrile seizures in children born very preterm: Relation of neonatal, febrile and epileptic seizures and neurological dysfunction to seizure outcome at 16 years of age. Seizure 15(8), 590-597 (2006
5. Visser AM, Jaddoe VW, Hofman A et al. Fetal growth retardation and risk of febrile seizures. Pediatrics 126(4), e919-e925 (2010
6. Vestergaard M, Christensen J. Registerbased studies on febrile seizures in Denmark. Brain Dev. 31(5), 372-377 (2009
7. Takano T, Sakaue Y, Sokoda T et al. Seizure susceptibility due to antihistamines in febrile seizures. Pediatr. Neurol. 42(4), 277-279 (2010
8. Nelson KB, Ellenberg JH. Predictors of epilepsy in children who have experienced febrile seizures. N. Engl. J. Med. 295(19), 1029-1033 (1976
9. Annegers JF, Hauser WA, Shirts SB, Kurland LT. Factors prognostic of unprovoked seizures after febrile convulsions. N. Engl. J. Med. 316(9), 493-498 (1987
10. Millichap JG, Millichap JJ. Role of viral infections in the etiology of febrile seizures. Pediatr. Neurol. 35(3), 165-172 (2006
11. Kohl KS, Marcy SM, Blum M et al.; Brighton Collaboration Fever Working Group. Fever after immunization: Current concepts and improved future scientific understanding. Clin. Infect. Dis. 39(3), 389-394 (2004
12. Brown NJ, Berkovic SF, Scheffer IE. Vaccination, seizures and 'vaccine damage'. Curr. Opin. Neurol. 20(2), 181-187 (2007
13. Peltola H, Heinonen OP. Frequency of true adverse reactions to measles-mumps-rubella vaccine. A double-blind placebo-controlled trial in twins. Lancet 1(8487), 939-942 (1986
14. Griffin MR, Walker FJ, Iwane MK, Weinberg GA, Staat MA, Erdman DD; New Vaccine Surveillance Network Study Group. Epidemiology of respiratory infections in young children: Insights from the new vaccine surveillance network. Pediatr. Infect. Dis. J. 23(11 Suppl), S188-S192 (2004
15. van Stuijvenberg M, de Vos S, Tjiang GC, Steyerberg EW, Derksen-Lubsen G, Moll HA. Parents' fear regarding fever and febrile seizures. Acta Paediatr. 88(6), 618-622 (1999
16. O'Leary ST, Suh CA, Marin M; Vaccine Policy Collaborative Initiative. Febrile seizures and measles-mumps-rubella-varicella (MMRV) vaccine: What do primary care physicians think? Vaccine 30(48), 6731-6733 (2012
17. Tro-Baumann B, von Spiczak S, Lotte J et al. A retrospective study of the relation between vaccination and occurrence of seizures in Dravet syndrome. Epilepsia 52(1), 175-178 (2011
18. Baker JP. The pertussis vaccine controversy in Great Britain, 1974-1986. Vaccine 2, 14003-14010 (2003
19. Berkovic SF, Harkin L, McMahon JM et al. De-novo mutations of the sodium channel gene SCN1A in alleged vaccine encephalopathy: A retrospective study. Lancet Neurol. 5(6), 488-492 (2006
20. McIntosh AM, McMahon J, Dibbens LM et al. Effects of vaccination on onset and outcome of Dravet syndrome: A retrospective study. Lancet Neurol. 9(6), 592-598 (2010
21. Institute of Medicine, Committee to review the adverse consequences of pertussis and rubella vaccines. Adverse Effects Of Pertussis And Rubella Vaccines. National Academy Press, Washington, DC, USA (1991
22. Farrington P, Pugh S, Colville A et al. A new method for active surveillance of adverse events from diphtheria/tetanus/ pertussis and measles/mumps/rubella vaccines. Lancet 345(8949), 567-569 (1995
23. Barlow WE, Davis RL, Glasser JW et al.; Centers for Disease Control and Prevention Vaccine Safety Datalink Working Group. The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. N. Engl. J. Med. 345(9), 656-661 (2001
24. Hampl SD, Olson LC. Pertussis in the young infant. Semin. Respir. Infect. 10(1), 58-62 (1995
25. Singh M, Lingappan K. Whooping cough: The current scene. Chest 130(5), 1547-1553 (2006
26. Greco D, Salmaso S, Mastrantonio P et al. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group. N. Engl. J. Med. 334(6), 341-348 (1996
27. Gustafsson L, Hallander HO, Olin P, Reizenstein E, Storsaeter J. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N. Engl. J. Med. 334(6), 349-355 (1996
28. Trollfors B, Taranger J, Lagergärd T et al. A placebo-controlled trial of a pertussistoxoid vaccine. N. Engl. J. Med. 333(16), 1045-1050 (1995
29. Decker MD, Edwards KM, Steinhoff MC et al. Comparison of 13 acellular pertussis vaccines: Adverse reactions. Pediatrics 96(3 Pt 2), 557-566 (1995
30. Andrews N, Stowe J, Wise L, Miller E. Post-licensure comparison of the safety profile of diphtheria/tetanus/whole cell pertussis/haemophilus influenza type b vaccine and a 5-in-1 diphtheria/tetanus/ acellular pertussis/haemophilus influenza type b/polio vaccine in the United Kingdom. Vaccine 28(44), 7215-7220 (2010
31. Huang WT, Gargiullo PM, Broder KR et al.; Vaccine Safety Datalink Team. Lack of association between acellular pertussis vaccine and seizures in early childhood. Pediatrics 126(2), 263-269 (2010
32. Sun Y, Christensen J, Hviid A et al Risk of febrile seizures and epilepsy after vaccination with diphtheria, tetanus, acellular pertussis, inactivated poliovirus, and Haemophilus influenzae type B. JAMA 307(8), 823-831 (2012
33. Rosenthal S, Chen R, Hadler S. The safety of acellular pertussis vaccine vs whole-cell pertussis vaccine. A postmarketing assessment. Arch. Pediatr. Adolesc. Med. 150(5), 457-460 (1996
34. Griffin MR, Ray WA, Mortimer EA, Fenichel GM, Schaffner W. Risk of seizures after measles-mumps-rubella immunization. Pediatrics 88(5), 881-885 (1991
35. Miller E, Andrews N, Stowe J, Grant A, Waight P, Taylor B. Risks of convulsion and aseptic meningitis following measlesmumps- rubella vaccination in the United Kingdom. Am. J. Epidemiol. 165(6), 704-709 (2007
36. Davis RL, Marcuse E, Black S et al. MMR2 immunization at 4 to 5 years and 10 to 12 years of age: A comparison of adverse clinical events after immunization in the Vaccine Safety Datalink project. The Vaccine Safety Datalink Team. Pediatrics 100(5), 767-771 (1997
37. Centers for Disease Control and Prevention. Adverse Events Following Immunization. US Department of Health and Human Services, Public Health Service, CDC, Atlanta, GA, USA. Surveillance Report no. 3, 1985-1986 (1989
38. Centers for Disease Control and Prevention. Measles, mumps, and rubella - vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb. Mortal. Wkly. Rep. 47(No. RR-8), 38-39 (1998
39. Centers for Disease Control and Prevention. Update: Recommendations from the Advisory Committee on Immunization Practices (ACIP) regarding administration of combination MMRV vaccine. MMWR Morb. Mortal. Wkly. Rep. 57, 258-260 (2008
40. Jacobsen SJ, Ackerson BK, Sy LS et al. Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care setting. Vaccine 27(34), 4656-4661 (2009
41. Klein NP, Fireman B, Yih WK et al.; Vaccine Safety Datalink. Measles-mumpsrubella- varicella combination vaccine and the risk of febrile seizures. Pediatrics 126(1), e1-e8 (2010
42. Centers for Disease Control and Prevention. Update: Recommendations from the Advisory Committee on Immunization Practices (ACIP) regarding administration of combination MMRV vaccine. MMWR Morb. Mortal. Wkly. Rep. 57, 258-260 (2008
43. Klein NP, Lewis E, Baxter R et al. Measles-containing vaccines and febrile seizures in children age 4 to 6 years. Pediatrics 129(5), 809-814 (2012
44. Marin M, Broder KR, Temte JL, Snider DE, Seward JF; Centers for Disease Control and Prevention (CDC). Use of combination measles, mumps, rubella, and varicella vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. Recomm. Rep. 59(RR-3), 1-12 (2010
45. Hambidge SJ, Glanz JM, France EK et al.; Vaccine Safety Datalink Team. Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old. JAMA 296(16), 1990-1997 (2006
46. Greene SK, Kulldorff M, Lewis EM et al. Near real-time surveillance for influenza vaccine safety: Proof-of-concept in the Vaccine Safety Datalink Project. Am. J. Epidemiol. 171(2), 177-188 (2010
47. Glanz JM, Newcomer SR, Hambidge SJ et al. The safety of trivalent inactivated influenza vaccine in children ages 24 to 59 months. Arch. Pediatr. Adolesc. Med. 165, 749-755 (2011
48. Lee GM, Greene SK, Weintraub ES et al.; Vaccine Safety Datalink Project. H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project. Am. J. Prev. Med. 41(2), 121-128 (2011
49. Salmon DA, Akhtar A, Mergler MJ et al.; H1N1 Working Group of Federal Immunization Safety Task Force. Immunization-safety monitoring systems for the 2009 H1N1 monovalent influenza vaccination program. Pediatrics 127 Suppl 1, S78-S86 (2011
50. Stowe J, Andrews N, Bryan P, Seabroke S, Miller E. Risk of convulsions in children after monovalent H1N1 (2009) and trivalent influenza vaccines: A database study. Vaccine 29(51), 9467-9472 (2011
51. Armstrong PK, Dowse GK, Effler PV et al. Epidemiological study of severe febrile reactions in young children in Western Australia caused by a 2010 trivalent inactivated influenza vaccine. BMJ Open 1(1), e000016 (2011
52. Blyth CC, Currie AJ, Wiertsema SP et al. Trivalent influenza vaccine and febrile adverse events in Australia, 2010: Clinical features and potential mechanisms. Vaccine 29(32), 5107-5113 (2011
53. Department of Health and Aging, editor. Investigation into febrile reactions in young children following 2010 seasonal trivalent influenza vaccination. Australian Government Therapeutic Goods Administration (2010
54. Centers for Disease Control and Prevention. Update: Recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding use of CSL seasonal influenza vaccine (Afluria) in the United States During 2010-11. MMWR Morb. Mortal. Wkly Rep. 59, 989-992 (2010
55. Petousis-Harris H, Poole T, Turner N, Reynolds G. Febrile events including convulsions following the administration of four brands of 2010 and 2011 inactivated seasonal influenza vaccine in NZ infants and children: The importance of routine active safety surveillance. Vaccine 30(33), 4945-4952 (2012
56. Kelly HA, Skowronski DM, De Serres G, Effler PV. Adverse events associated with 2010 CSL and other inactivated influenza vaccines. Med. J. Aust. 195(6), 318-320 (2011
57. Maraskovsky E, Rockman S, Dyson A et al. Scientific investigations into febrile reactions observed in the paediatric population following vaccination with a 2010 Southern Hemisphere Trivalent Influenza Vaccine. Vaccine 30(51), 7400-7406 (2012
58. Bussfeld D, Kaufmann A, Meyer RG, Gemsa D, Sprenger H. Differential mononuclear leukocyte attracting chemokine production after stimulation with active and inactivated influenza A virus. Cell. Immunol. 186(1), 1-7 (1998
59. Hayden FG, Fritz R, Lobo MC, Alvord W, Strober W, Straus SE. Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J. Clin. Invest. 101(3), 643-649 (1998
60. Masuyama T, Matsuo M, Ichimaru T, Ishii K, Tsuchiya K, Hamasaki Y. Possible contribution of interferon-alpha to febrile seizures in influenza. Pediatr. Neurol. 27(4), 289-292 (2002
61. Leroy Z, Broder K, Menschik D, Shimabukuro T, Martin D. Febrile seizures after 2010-2011 influenza vaccine in young children, United States: A vaccine safety signal from the vaccine adverse event reporting system. Vaccine 30(11), 2020-2023 (2012
62. Tse A, Tseng HF, Greene SK, Vellozzi C, Lee GM; VSD Rapid Cycle Analysis Influenza Working Group. Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011. Vaccine 30(11), 2024-2031 (2012
63. Esposito S, Pugni L, Daleno C et al. Influenza A/H1N1 MF59-adjuvanted vaccine in preterm and term children aged 6 to 23 months. Pediatrics 127(5), e1161-e1168 (2011
64. Nolan T, Bernstein DI, Block SL et al.; LAIV Study Group. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age. Pediatrics 121(3), 508-516 (2008
65. Poland GA, Ovsyannikova IG, Jacobson RM. Application of pharmacogenomics to vaccines. Pharmacogenomics 10(5), 837-852 (2009
66. Pittman PR, Gibbs PH, Cannon TL, Friedlander AM. Anthrax vaccine: Short-term safety experience in humans. Vaccine 20(5-6), 972-978 (2001
67. Broder KR, Martin DB, Vellozzi C. In the heat of a signal: Responding to a vaccine safety signal for febrile seizures after 2010-11 influenza vaccine in young children, United States. Vaccine 30(11), 2032-2034 (2012
68. Esposito S, Marchisio P, Montinaro V et al. The immunogenicity and safety of a single 0.5 mL dose of virosomal subunit influenza vaccine administered to unprimed children aged =6 to
69. Mallory RM, Malkin E, Ambrose CS et al. Safety and immunogenicity following administration of a live, attenuated monovalent 2009 H1N1 influenza vaccine to children and adults in two randomized controlled trials. PLoS ONE 5(10), e13755 (2010
70. Lewis K, Cherry JD, Sachs MH et al. The effect of prophylactic acetaminophen administration on reactions to DTP vaccination. Am. J. Dis. Child. 142(1), 62-65 (1988
71. Ipp MM, Gold R, Greenberg S et al. Acetaminophen prophylaxis of adverse reactions following vaccination of infants with diphtheria-pertussis-tetanus toxoids-polio vaccine. Pediatr. Infect. Dis. J. 6(8), 721-725 (1987
72. Centers for Disease Control and Prevention. Pertussis vaccination: Use of acellular pertussis vaccines among infants and young children - recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb. Mortal. Wkly Rep. 46(RR-7), 19 (1997
73. Vesikari T, Esposito S, Prymula R et al.; EU Meningococcal B Infant Vaccine Study group. Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: Results of two randomised trials. Lancet 381(9869), 825-835 (2013